Preliminary scientific tests point out conolidine may inhibit unique ion channels, lessening neuronal excitability and limiting discomfort signals. This mechanism is especially related in neuropathic agony, wherever abnormal signaling leads to persistent soreness. On top of that, conolidine seems to affect G protein-coupled receptor (GPCR) pathways integral to soreness https://jonathanm470awa3.wiki-jp.com/user